![Michael A. Yamin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael A. Yamin
Nessuna posizione attualmente
Profilo
Michael A.
Yamin served as the Director & Vice President at Angion Biomedica Corp.
from 2013 to 2020.
Prior to that, he obtained a doctorate degree from The Rockefeller University.
Precedenti posizioni note di Michael A. Yamin
Società | Posizione | Fine |
---|---|---|
ANGN BIOM | Direttore/Membro del Consiglio | 04/06/2020 |
Formazione di Michael A. Yamin
The Rockefeller University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Angion Biomedica Corp.
![]() Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Borsa valori
- Insiders
- Michael A. Yamin